RAD-140 vs Winstrol
Emerging vs Well Studied
avoid Mechanism-based · 53% Both RAD-140 and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
RAD-140 Winstrol
Weight 393.83 Da 328.49 Da
Half-life ~60 hours ~9 hours (oral), ~24 hours (injectable)
Type Nonsteroidal selective androgen receptor modulator (C20H16ClN5O2) 17-alpha-alkylated anabolic-androgenic steroid (C21H32N2O)
Key Benefits
RAD-140
01 Potent anabolic activity in muscle tissue with high oral bioavailability
02 Tissue-selective action sparing the prostate and other androgen-sensitive organs
03 No aromatization to estrogen (no estrogen-related side effects such as water retention or gynecomastia)
04 No conversion to DHT (reduced risk of hair loss and prostate stimulation compared to testosterone)
05 Long half-life (~60 hours) permitting convenient once-daily oral dosing
06 Neuroprotective properties observed in preclinical models
07 Increased lean body mass and reduced fat mass in preclinical studies
Winstrol
01 Produces a dry, hard, and vascular appearance without water retention
02 Significant strength increases without proportional weight gain, favored in weight-class sports
03 Does not aromatize to estrogen, eliminating gynecomastia and bloating concerns
04 Potent suppression of SHBG, increasing free testosterone and enhancing the effectiveness of stacked compounds
05 Available in both oral and injectable formulations
06 High anabolic-to-androgenic ratio (320:30) relative to methyltestosterone
07 FDA-approved for hereditary angioedema prophylaxis
08 Enhances vascularity and muscle definition during caloric deficit
Dosing Protocols
RAD-140
10-20 mg/day / Once daily (oral)
Winstrol
25-50 mg/day (oral), 50 mg EOD (injectable) / Daily (oral) or every other day (injectable)
Performance - Standard Injectable 50 mg every other day Every other day (EOD)
Side Effects
RAD-140
Testosterone suppression (dose-dependent, occurs in virtually all users by week 4-6)
Liver enzyme elevation (ALT, AST increases reported in clinical and anecdotal data)
Hair shedding (temporary, typically resolves after discontinuation)
Headaches (most common in the first 1-2 weeks, often transient)
Nausea (mild, usually with initial doses or on an empty stomach)
Lipid disruption (HDL suppression, LDL elevation)
Mild insomnia or sleep disturbance
Reduced libido and mood changes related to testosterone suppression
Winstrol
Severe HDL cholesterol suppression (winstrol is among the worst oral steroids for lipid damage)
Significant LDL cholesterol elevation
Joint dryness and pain, particularly in knees, shoulders, and elbows (notorious side effect)
Hepatic stress with elevated liver enzymes (ALT/AST)
Suppression of endogenous testosterone production
Hair loss and accelerated male pattern baldness (DHT derivative, particularly harsh on hairline)
Acne and oily skin
Tendon and ligament stress due to rapid strength gains combined with reduced joint lubrication
Dry, painful shin splints during cardiovascular exercise
Contraindications
Pre-existing liver disease or elevated liver enzymes at baseline
Hormone-sensitive cancers (prostate cancer, certain breast cancers not being treated under clinical supervision)
Pregnancy or potential pregnancy (teratogenic risk from androgen receptor agonism)
Breastfeeding
Age under 25 (incomplete endocrine system maturation and higher risk of HPG axis disruption)
Concurrent use of hepatotoxic medications without medical supervision
Known cardiovascular disease (insufficient safety data for this population)
Known or suspected prostate cancer
Breast cancer in males
Breast cancer with hypercalcemia in females
Pregnancy (Category X - known to cause fetal harm)
Severe hepatic dysfunction or active liver disease
Nephrosis or nephrotic phase of nephritis
Pre-existing severe cardiovascular disease or dyslipidemia
Hypersensitivity to stanozolol or any formulation component
Research Evidence
RAD-140 Winstrol
Status Emerging Well Studied
References 5 studies 5 studies
Latest July 2020 June 2023
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.